Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Pancreatic Neoplasms × Folfox protocol × Clear all

Phase

Status

Completed 5 Withdrawn 1 Unknown 1 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 20 Colonic Neoplasms 11 Rectal Neoplasms 10 Carcinoma, Hepatocellular 10 Stomach Neoplasms 5 Digestive System Neoplasms 3 Neurotoxicity Syndromes 2 Neoplasms 2 Neoplasm Metastasis 2 Gastrointestinal Neoplasms 2 Gastrointestinal Diseases 2 Recurrence 1 Peripheral Nervous System Diseases 1 Pancreatic Neoplasms 1 Pancreatic Adenocarcinoma 1 Neoadjuvant Therapy 1 Liver Neoplasms 1 Intestinal Neoplasms 1 Cholangiocarcinoma 1 Carcinoma 1

Interventions

Gemcitabine 63 Fluorouracil 22 130-nm albumin-bound paclitaxel 19 Oxaliplatin 18 Leucovorin 13 Capecitabine 13 S 1 (combination) 12 Albumin-Bound Paclitaxel 12 Taxes 9 Radiosurgery 9 folfirinox 8 Irinotecan 8 Radiotherapy 6 Cisplatin 6 pembrolizumab 5 Pancreaticoduodenectomy 5 Drug Therapy 5 irinotecan sucrosofate 4 apatinib 4 Radiofrequency Ablation 4 Paclitaxel 4 Injections 4 Blood Specimen Collection 4 Biopsy 4 tislelizumab 3 rubitecan 3 Stents 3 Sorafenib 3 Radiation 3 Nivolumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03666832 2022-06-15

MP-PDAC-01

Samsung Medical Center

Phase 1/2 Unknown

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡